Genomic Systems announces 'moratorium on studying and treating terminal cancer has ended'
Genomic Systems announces a major breakthrough in treating terminal cancer, citing research published in PNAS that shows an anti-PECAM-1 antibody is effective against three common fatal cancers in mice. The treatment targets normal endothelial cells rather than directly attacking cancer cells.